US FDA approves Vertex's non-opioid painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
The American Journal of Managed Care1h
Suzetrigine: First-in-Class Non-Opiate Pain Therapy is Approved by FDA
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
The New Times on MSN2h
Doping may not be a big issue in Rwanda yet but for how long?
The rising pressure of fame and money is accelerating doping in sports worldwide and across all fields, but can Rwanda really and seriously tackle the issue? The quest for fame, fortune, and the drive ...
An Unprecedented 22 Percent Drop in Drug Deaths Does Not Mean Prohibition Is Finally Working
During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...
The News-Gazette2h
Push for prescription drug affordability board revived
With prescription drug costs soaring, Illinois lawmakers announced legislation this week reviving efforts to create a ...
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...